Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
9
NMPA:9
Drug Approvals
Fluvoxamine Maleate Tablets
- Product Name
- 马来酸氟伏沙明片
- Approval Number
- 国药准字H20254294
- Approval Date
- May 27, 2025
NMPA
Fluvoxamine Maleate Tablets
- Product Name
- 马来酸氟伏沙明片
- Approval Number
- 国药准字H20254293
- Approval Date
- May 27, 2025
NMPA
Propafenone Hydrochloride Tablets
- Product Name
- 悦复隆/Rytmonorm
- Approval Number
- 国药准字H20237100
- Approval Date
- Aug 30, 2023
NMPA
Valsartan and Amlodipine Tablets（Ⅱ）
- Product Name
- 缬沙坦氨氯地平片(Ⅱ)
- Approval Number
- 国药准字H20223139
- Approval Date
- Mar 16, 2022
NMPA
Valsartan and Amlodipine Tablets （Ⅰ）
- Product Name
- 缬沙坦氨氯地平片(Ⅰ)
- Approval Number
- 国药准字H20213777
- Approval Date
- Oct 11, 2021
NMPA
Clinical Trials
No trials found
News
No news found